CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2020
Market Capitalization	16,088	12,674	28,030	-	-	-	Upgrade
Market Cap Growth	-54.78%	-54.78%	-	-	-	-	Upgrade
Last Close Price	31.21	24.59	53.69	-	-	-	Upgrade
PE Ratio	-	-	6.59	-	-	-	Upgrade
PS Ratio	1.27	1.00	1.26	-	-	-	Upgrade
PB Ratio	0.83	0.65	1.13	-	-	-	Upgrade
Debt / Equity Ratio	0.72	0.72	1.29	1.96	2.09	1.25	Upgrade
Return on Equity (ROE)	-23.48%	-23.48%	20.23%	19.34%	3.96%	8.65%	Upgrade
Return on Assets (ROA)	-1.96%	-1.96%	1.84%	1.59%	0.36%	0.97%	Upgrade
Earnings Yield	-32.41%	-41.14%	15.18%	-	-	-	Upgrade
FCF Yield	-23.93%	-30.38%	-152.43%	-	-	-	Upgrade
Dividend Yield	2.24%	-	1.30%	-	-	-	Upgrade
Buyback Yield / Dilution	-8.15%	-8.15%	-5.68%	-0.04%	-5.21%	-0.00%	Upgrade
Total Shareholder Return	-5.91%	-8.15%	-4.38%	-0.04%	-5.21%	-0.00%	Upgrade

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.